openPR Logo
Press release

Osteoporosis Drugs Market Compnies Size, FuSSture Trends, Segmentation, Gross Margin, Opportunity Assessment

10-14-2020 10:46 AM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research (TMR) has published a new report titled, ‘Osteoporosis Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Osteoporosis Drugs market was valued at US$ 11.5 Bn in 2018 and is projected to contract at a CAGR of 0.3% from 2019 to 2027.

Overview

Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone fragility and threat of bone cracks and fractures. Thus, osteoporosis is considered life threatening due to severe injury and associated pain.
Elevation in threat of bone cracks and introduction of new drug therapy classes are the factors that are fuelling the growth of osteoporosis drugs market. Since there is no distinct substitute available to treat osteoporosis (such as, surgery), the drugs therapy is an inevitable part of osteoporosis treatment
Get Brochure of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=133

Growing aging population leads for higher prevalence of osteoporosis which brings more growth opportunities for osteoporosis drugs market.
North America dominated the global osteoporosis drugs market in 2018 and the trend is anticipated to continue during the forecast period. Higher osteoporosis incidence & prevalence rate, presence of major companies, and better diagnosis rate for the diseases are some of the major factors to dive the market in this region.
Rise in prevalence of osteoporosis across the globe to Drive Market

Higher incidence & prevalence of osteoporosis across the world is the major driver for the growth of global osteoporosis market.
Request For Covid19 Impact Analysis –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=133

For instance, according to International Osteoporosis Foundation, Osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds and also it is estimated to affect 200 million women globally.
Moreover growing aging population aged above 50 years are at the greatest risk of developing osteoporosis and related fractures due to hormonal changes. So this rise in aging population also fuelling the growth of global market.
Development of novel approaches for the treatment of osteoporosis by new drugs and increase in awareness among people for the early diagnosis & treatment are also some of the major factors for the growth of this market.
Buy Report Now : https://www.transparencymarketresearch.com/checkout.php?rep_id=133<ype=S

Bisphosphonates Segment to Dominate Market

Based on drug class, the global osteoporosis drugs market has been divided into Bisphosphonates, Calcitonin, RANK Ligand Inhibitors, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, and others.
RANK ligand inhibitors dominated the market in 2018 due to market exclusivity of branded drugs and its efficacy to treat osteoporosis. However this segment is projected to lose its market share by the end of 2027 due to patent expiration and generics availability.
Bisphosphonates segment is projected to dominate by the end of 2027 to first mover advantage for this class and extensive prescriptions of bisphosphonates in osteoporosis treatment.
Sclerostin Inhibitor segment is expected to grow with higher CAGR during the forecast period owing to novel approach for of the drug for osteoporosis treatment and recent launch of product in 2019.
North America to Dominate Global Market

In terms of region, the global osteoporosis drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for major share of the global osteoporosis drugs market in 2018, owing to higher prevalence of osteoporosis, recent approval of drugs in the region, and early diagnosis of disease.
For instance, as per International Osteoporosis Foundation, osteoporosis and low bone mass are currently estimated to be a major public health threat for almost 44 million U.S. women and men aged 50 and older
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

The Osteoporosis Drugs market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to growing aging population, higher demand of branded as well as generic products for osteoporosis, and increased awareness towards diagnosis & management of osteoporosis, and preference of population towards drugs with less side-effect.
Competitive Landscape

The global Osteoporosis Drugs market is fragmented in terms of number of players. Key players in the global market include Eli Lilly and Company, Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Radius Health, Inc. , Novartis AG, Teva Pharmaceutical Industries Ltd., Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., UCB S.A., Mylan N.V., and Apotex Inc. among others
The global Osteoporosis Drugs market has been segmented as follows:

Global Osteoporosis Drugs Market, by Drug ClassBisphosphonates
Calcitonin
RANK Ligand Inhibitor
Parathyroid Hormone Therapy (PTH)
Selective Estrogen Receptor Modulators (SERMs)
Sclerostin Inhibitor
Others
Global Osteoporosis Drugs Market, by RegionNorth AmericaU.S.
Canada
EuropeGermany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin AmericaBrazil
Mexico
Rest of Latin America
Middle East & AfricaGCC Countries
South Africa
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/global-chronic-obstructive-pulmonary-disease-copd-treatment-market-to-reach-us-26-2-bn-in-2027-drug-makers-focus-on-combination-therapies-transparency-market-research-301011476.html

Contact

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoporosis Drugs Market Compnies Size, FuSSture Trends, Segmentation, Gross Margin, Opportunity Assessment here

News-ID: 2158912 • Views: 120

More Releases from Transparency Market Research

Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals

All 5 Releases


More Releases for Osteoporosis

2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022 The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%. Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone
Global Osteoporosis Drugs Sales Market Report 2017
Summary: Report Hive Market Research Released a New Research Report of 100 pages on Title " Global Osteoporosis Drugs Sales Market Report 2017 "with detailed Analysis, Forecast and Strategies. Description: In this report, the global Osteoporosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews February 03, 2017 Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related
Recent Press Release Updates Global Osteoporosis Market
MarketResearchReports.Biz is providing you Retail Market Research report of "Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017". Latest Report, Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Osteoporosis Report is to understand the market and pipeline status of the drugs around the Osteoporosis
Growth Postmenopausal Osteoporosis Therapeutics Market: 2015 - 2021
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The